European researchers identify genetic determinants of deafness
September 1 is World Deafness Day
Deafness is a real heath problem in Europe
Deafness is a real and often underestimated health problem in Europe: 6% of the European population suffer of hearing impairment. It is now known that over 50% of all hearing impairments is caused by genetic factor. Over the last 7 years, the European Commission has channelled more than €10 million into research on different aspects of deafness. One particular project receiving support from the European Commission identified several genes which when affected lead to inherited deafness in humans. These discoveries increase significantly our understanding of the hearing process and open avenues for new therapies for deafness.
On the occasion of World Deafness Day on 1 September, European Research Commissioner Philippe Busquin said: “The number of patients suffering of hearing impairment is constantly growing due to increased noise pollution and to an ageing population. So far, aside from hearing aids, there is no remedy for deafness. Developing new therapies requires the best researchers from different countries and disciplines to work together in order to improve our knowledge on the hearing process and to identify the causes leading to deafness. This is precisely what the EU is making to happen through its research programmes.”
In Europe, 22.5 million individuals suffer form hearing impairment with 2 million profoundly deaf. In children, deafness impedes language acquisition and generates learning difficulties. In adults, if often leads to severe disruption of social links which very frequently results in depression. All together, in Europe, the financial cost of hearing impairment has been estimated to be €78 billion per year (based on average of €3,500 per patient annual costs for special education, speech therapy, hearing aids, physician and specialists fees, and other expenses). This is more than the combined economic costs of epilepsy, multiple sclerosis, spinal injury, stroke and Parkinson’s disease. Furthermore, this figure is likely to grow continuously in time due to noise pollution and ageing. Hearing loss is the third leading chronic disability following arthritis and hypertension.
Research on deafness is a European priority
The European Commission is supporting research on deafness for many years. In particular, the project “hereditary deafness” co-ordinated by Prof. Christine Petit (Pasteur Institute, Paris, France) allowed substantial progress in the understanding of the hearing process and in the identification of the genetic determinants of deafness. 50 % of the hearing deficiencies have a genetic origin. Importantly, this consortium of leading European researchers identified half of the 36 genes known to be associated with deafness. One of these genes, “connexin 26” was found to be responsible for more than 30% of deafness cases in Europe. The identification of the genetic determinants is crucial for diagnosing the underlying causes of deafness. These diagnostic tools are now available and can be used in a very large proportion of cases of deafness to identify the genetic origin of their hearing impairment.
Furthermore, this research has considerably increased our knowledge of the hearing mechanism: i.e. how a wave sound can be transmitted from the outer ear to the inner ear and be sent to the brain as an electrical signal. These discoveries open new avenues for developing innovative therapies for deafness. Several mouse models have also been developed mimicking the human hearing impairments. They will be very useful for testing new therapeutic approaches.
All together, this European effort has considerably increased our knowledge on this important health problem. However, we are still far from understanding the complete picture and most importantly there is still a long way before having new potential therapies for deafness. This is why the European Commission has made deafness a research priority in the second call for proposals of the Sixth Framework Programme published in July 2003, inviting large European projects to study the hearing process and deafness.
Jacques Remacle | alfa
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.
The results will be published on March 22 in the journal „Astronomy & Astrophysics“.
Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...
Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.
Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...
Layered 2D material improves efficiency for solar cells and LEDs
In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...